TransMedics (TMDX) Return on Capital Employed Growth (1y) (2020 - 2026)
TransMedics (TMDX) Return on Capital Employed Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 658.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 125.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -3,185.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TransMedics | 2.45 Bn | 1.98 Bn | 101.16 Mn | 128.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 128.00 |
| Dec 31, 2025 | 673.00 |
| Sep 30, 2025 | 703.00 |
| Jun 30, 2025 | 960.00 |
| Mar 31, 2025 | 900.00 |
| Dec 31, 2024 | 957.00 |
| Sep 30, 2024 | 1,037.00 |
| Jun 30, 2024 | 324.00 |
| Mar 31, 2024 | 739.00 |
| Dec 31, 2023 | 799.00 |
| Sep 30, 2023 | 1,457.00 |
| Jun 30, 2023 | 3,972.00 |
| Mar 31, 2023 | 2,920.00 |
| Dec 31, 2022 | 2,346.00 |
| Sep 30, 2022 | 783.00 |
| Jun 30, 2022 | -2,208.00 |
| Mar 31, 2022 | -2,059.00 |
| Dec 31, 2021 | -1,757.00 |
| Mar 31, 2021 | 1,864.00 |
| Dec 31, 2020 | 1,354.00 |